Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is the primary treatment for non-muscle-invasive bladder cancer (NMIBC), known to stimulate inflammatory cytokines, notably interferon (IFN)-γ. We observed that prolonged IFN-γ exposure fosters adaptive resistance in recurrent tumors, aiding immune evasion and tumor proliferation. We identify HLA-E and NKG2A, part of a novel NK and T cell checkpoint pathway, as key mediators of resistance in BCG-unresponsive NMIBC. IFN-γ enhances HLA-E and PD-L1 expression in recurrent tumors, with an enrichment of intra-tumoral NKG2A-expressing NK and CD8 T cells. CXCL9 + macrophages and dendritic cells and CXCL12-expressing stromal cells likely recruit CXCR3/CXCR4-expressing NK and T cells and CXCR7 + HLA-E HIGH tumor cells. NK and CD8 T cells remain functional within BCG-unresponsive tumors but are inhibited by HLA-E and PD-L1, providing a framework for combined NKG2A and PD-L1 blockade strategy for bladder-sparing treatment of BCG-unresponsive NMIBC.
bioRxiv : the preprint server for biology. 2024 Sep 03*** epublish ***
D Ranti, H Yu, Y A Wang, C Bieber, T Strandgaard, B Salomé, Sean Houghton, J Kim, H Ravichandran, I Okulate, E Merritt, S Bang, A Demetriou, Z Li, S V Lindskrog, D F Ruan, J Daza, R Rai, E Hegewisch-Solloa, E M Mace, R Fernandez-Rodriguez, S Izadmehr, G Doherty, A Narasimhan, A M Farkas, P Cruz-Encarnacion, S Shroff, F Patel, M Tran, S J Park, J Qi, M Patel, D Geanon, G Kelly, R M de Real, B Lee, K Nie, S Miake-Iye, K Angeliadis, E Radkevich, T H Thin, M Garcia-Barros, H Brown, B Martin, A Mateo, A Soto, R Sussman, S Shiwlani, S Francisco-Simon, K G Beaumont, Y Hu, Y-C Wang, L Wang, R P Sebra, S Smith, M Skobe, E Clancy-Thompson, D Palmer, S Hammond, B D Hopkins, P Wiklund, J Zhu, J J Bravo-Cordero, R Brody, B Hopkins, Z Chen, S Kim-Schulze, L Dyrskjøt, O Elemento, A Tocheva, W-M Song, N Bhardwaj, M D Galsky, J P Sfakianos, A Horowitz